Where Are You in Your Journey?
Explore resources designed to help you understand the clinical value, patient considerations, and real-world applications of the Aerobika* OPEP device.
Explore tools and resources designed to support patient selection, treatment discussions, clinical implementation, and ongoing patient success.
Explore resources designed to streamline patient conversations, support the value behind consistent product use, and simplify integration into practice.
Access a curated summary of clinical evidence supporting the efficacy and value of the Aerobika* OPEP device in improving the lives of patients with bronchiectasis, COPD, cystic fibrosis, and other respiratory conditions. You can access this document here.
How the Aerobika* OPEP Device Works
Join respiratory experts Dr. Allen Greenwald, Respirologist, and Isabelle LeClerc, RN, as they look to define and differentiate bronchiectasis to help break the vicious cycle of disease progression.
Access a summary of clinical evidence supporting the efficacy and value of the Aerobika* device in improving the lives of patients with bronchiectasis, COPD, cystic fibrosis, and other respiratory conditions.
Support more effective patient conversations with a practical patient support tool designed to help patients who may just be getting started; reinforcing education, technique and adherence.
Connect with a representative for clinical support, additional product details, and implementation resources or to explore how the Aerobika* OPEP device may support patients in your practice.
The Aerobika* Device Significantly Reduced Bronchiectasis Exacerbations14
A single-arm, prospective pilot study was conducted on frequently exacerbating (≥3 acute exacerbations in the past year) bronchiectasis patients (n = 17).
Evaluated the prevention of acute exacerbations, and quality of life during the use of the Aerobika* OPEP device twice daily for 6 months, following 12 months of standard of care without Aerobika* OPEP (the control).
Intervention was on top of current management (included ACBT and/or autogenic drainage).
Of all enrolled patients, only two total acute exacerbations occurred during the study period (p<0.001).
Think All OPEP Devices Are Created Equal? There's a Clear Choice.
Comparing the Aerobika* OPEP Device with the Acapella† Device and Flutter† Device
Explore clinical considerations that differentiate the Aerobika* device within OPEP therapy and may support effective airway clearance in bronchiectasis care.
Support more effective patient conversations with a practical patient support tool designed to help patients who may just be getting started; reinforcing education, technique and adherence.
Join respiratory experts Dr. Allen Greenwald, Respirologist, and Isabelle LeClerc, RN, as they look to define and differentiate bronchiectasis to help break the vicious cycle of disease progression.
Access a summary of clinical evidence supporting the efficacy and value of the Aerobika* device in improving the lives of patients with bronchiectasis, COPD, cystic fibrosis, and other respiratory conditions.
Connect with a representative for clinical support, additional product details, and implementation resources or to explore how the Aerobika* OPEP device may support patients in your practice.
You’re already familiar with the Aerobika* OPEP device and are using it in practice! This section is designed to support patient counselling, provide resources that help support patient adherence and technique, and gather feedback to understand how we can do more to best support you.
Support patients beyond the clinic visit with clear, easy-to-follow care instructions designed for use at home. Designed to reinforce proper use, cleaning, and maintenance.
Support more effective patient conversations with a practical patient support tool designed to help patients who may just be getting started; reinforcing education, technique and adherence.
We value partnerships with healthcare professionals who are passionate about improving patient care. We would love to explore ways to collaborate!
Don’t have everything you need? Share feedback on what’s working, what additional support would be helpful, and how we can better support you in your practice.
Have More Questions?
Get in Touch!
1. Svenningsen S, et al. COPD. 2106;13(1):66-74. 2. GOLD 2025 Report. 3. Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017; 50: 1700629. 4. Hill AT et al., British Thoracic Society Guideline for bronchiectasis. 5. Burudpakdee C, et al. Pulmonary Therapy 2017;3(1):163-171. 6. Kim SR, et al. Front Med (Lausanne). 2023 May 12;10:1159227. 7. Svenningsen S, et al. Academic Radiology. 2017;24(1):4-12. 8. Poirer C, et al. Presented at the Canadian Respiratory Conference. April 3 – 5, 2025. 8. Suggett J. COPD 10, 2016. UK. 9. Coppolo DP, et al. Pulm Ther. 2022 Mar 8: (1):1-41. 10. O’Donnell DE, et al. Thorax 2006;61:354-361 11. Suggett, J. et al. CHEST 2017 12. Coppolo, et al. Pulmonary Therapy (2021). 13. Van Fleet H, et al. Respiratory Care 2017;62(4):451-458. 14. Kim SR, et al. Effectiveness of the use of an oscillating positive expiratory pressure device in bronchiectasis with frequent exacerbations: a single-arm pilot study. Front Med (Lausanne). 2023 May 12;10:1159227.